Re: Anirban Dey, Georgios Georgiadis, Justin Umezurike, et al. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review. Eur Urol Focus. In press. https://doi:10.1016/j.euf.2024.09.012
Eur Urol Focus. 2024 Dec 16:S2405-4569(24)00259-1.
doi: 10.1016/j.euf.2024.11.013.
Online ahead of print.
1 Chengdu Center for Disease Control and Prevention, Chengdu, China.
2 Department of Pediatric Surgery, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology of China, Chengdu, China. Electronic address: 15882420198@163.com.